About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology and Bone Marrow Transplantation
›
top-articles
Department of Hematology and Bone Marrow Transplantation
33
(top 2%)
papers
1.2K
(top 2%)
citations
12
(top 2%)
h
-index
33
(top 2%)
g
-index
37
all documents
1.3K
doc citations
447
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
Blood
2005
595
2
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Proceedings of the National Academy of Sciences of the United States of America
2010
127
3
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis
Cancer
2010
99
4
Optimal induction and post-remission therapy for AML in first remission
Hematology American Society of Hematology Education Program
2009
77
5
Non‐Hodgkin's lymphoma presenting as an endobronchial tumor: Report of eight cases and literature review
American Journal of Hematology
2008
65
6
Granulocyte transfusions for neutropenic patients with life‐threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions
Vox Sanguinis
2007
42
7
Biology and therapy of secondary leukaemias
Best Practice and Research in Clinical Haematology
2001
38
8
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission—Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Cancer
2017
32
9
Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?
Thrombosis Research
2014
30
10
Optically Induced Cell Fusion Using Bispecific Nanoparticles
Small
2013
23
11
Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT
Bone Marrow Transplantation
2009
21
12
Interpreting Data on Transplant Selection and Outcome in Adult Acute Lymphoblastic Leukemia (ALL)
Biology of Blood and Marrow Transplantation
2011
13
13
The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation
Haematologica
2021
13
14
Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?
Leukemia
2005
12
15
Safe and Efficacious Allogeneic Bone Marrow Transplantation for Nonmalignant Disorders Using Partial T Cell Depletion and No Posttransplantation Graft-Versus-Host-Disease Prophylaxis
Biology of Blood and Marrow Transplantation
2007
12
16
Consolidation therapy: What should be the standard of care?
Best Practice and Research in Clinical Haematology
2008
12
17
Testicular lymphoma, intraocular (Vitreoretinal) lymphoma, and brain lymphoma: Involvement of three immunoprivileged sites in one patient
American Journal of Hematology
2010
12
18
Mental Disorders and Thrombotic Risk
Seminars in Thrombosis and Hemostasis
2013
12
19
Fatal Kaposi sarcoma after allogeneic stem cell transplant
Leukemia and Lymphoma
2011
6
20
Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome
American Journal of Hematology
2007
4
21
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice and Research in Clinical Haematology
2009
3
22
The evolving paradigm of prognostic factors in AML: Introduction to the Acute Leukemia Forum 2010
Best Practice and Research in Clinical Haematology
2010
3
23
Venous thromboembolism: Advances and controversies
Best Practice and Research in Clinical Haematology
2012
3
24
Phase I/II Trial Of Immucin a Pan HLA, Anti-MUC1 Signal Peptide Vaccine, In Multiple Myeloma Patients With Residual Disease Or Progression Following Autologous Stem Cell Transplantation
Blood
2013
3
25
Preface: significant advances in the biology and therapy of AML over the past four decades
Best Practice and Research in Clinical Haematology
2006
2
26
PF287 MIDOSTAURIN IN COMBINATION WITH INTENSIVE CHEMOTHERAPY IS SAFE AND ASSOCIATED WITH IMPROVED REMISSION AND HIGHER TRANSPLANT RATES IN REMISSION ‐ A MULTI‐CENTER HISTORICAL CONTROL STUDY
HemaSphere
2019
2
27
Microvesicles microRNAs Reflect and Affect Progression of Acute Myeloid Leukemia and Could Serve As a Biomarker of Disease Dynamics
Blood
2016
2
28
Clinical progress in acute myeloid leukemia
Best Practice and Research in Clinical Haematology
2008
1
29
Cancer and Thrombosis
Best Practice and Research in Clinical Haematology
2009
1
30
Reply to induction therapy and outcome in acute myeloid leukemia
Cancer
2011
1
31
Cell Fusion: Optically Induced Cell Fusion Using Bispecific Nanoparticles (Small 22/2013)
Small
2013
1
32
Soluble endothelial protein C receptor and coagulation parameters as prognostic factors in non-small cell lung carcinoma
Journal of Thrombosis and Haemostasis
2013
1
33
Acute Leukemia
2011
0
34
Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT
SSRN Electronic Journal
0
0
35
Prophylactic Therapy with Enoxaparin in Children with Acute Lymphoblastic Leukemia and Inherited Thrombophilia During L-Asparaginase Treatment.
Blood
2009
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.